Functional pancreatic insufficiency after surgical treatment in the light of the latest international recommendations

Cover Page


Cite item

Full Text

Abstract

Exocrine  and  endocrine   insufficiencies  are  frequent complications of surgical treatment for pancreatic diseases. The presence  and  extent  of the insufficiency depend on the underlying  disorder, type of surgical procedure, extent of pancreatic resection, and anatomical reconstruction. Increased surgical  activity  determines  the  importance  of the  evidence-based guidelines  for management of patients  after  pancreatic  surgery. The article presents  an  overview of international Evidence-based Guidelines for the Management of Exocrine Pancreatic  Insufficiency after  Pancreatic  Surgery (2016) and United European Gastroenterology evidence-based guidelines  for the  diagnosis  and therapy of chronic pancreatitis (HaPanEU, 2017).

About the authors

D. S. Bordin

Moscow Clinical Scientific Center, Moscow Healthcare Department; Tver State Medical University

Author for correspondence.
Email: d.bordin@mknc.ru

Bordin Dmitry S. – MD, PhD, Head of Division of Pathology of the Pancreas, Biliary Tract and Upper Digestive Tract MCSC, Professor of Chair of General Medical Practice (Family Medicine), Faculty of Postgraduate Studies TSMU, Scientific Secretary of the Russian Pancreatic Club

86 Shosse Entuziastov, Moscow, 111123, +7 (495) 304 95 51

Russian Federation

E. A. Dubtsova

Moscow Clinical Scientific Center, Moscow Healthcare Department

Email: fake@neicon.ru

Dubtsova Elena A. – MD, PhD, Head of Department of Pancreatic and Biliary Tract Pathology.

86 Shosse Entuziastov, Moscow, 111123

Russian Federation

L. V. Vinokurova

Moscow Clinical Scientific Center, Moscow Healthcare Department

Email: fake@neicon.ru

Vinokurova Lyudmila V. – MD, PhD, Leading Research Fellow, Department of Pancreatic and Biliary Tract Pathology.

86 Shosse Entuziastov, Moscow, 111123

Russian Federation

S. V. Kolbasnikov

Tver State Medical University

Email: fake@neicon.ru

Kolbasnikov Sergey V. – MD, PhD, Professor, Head of Chair of General Medical Practice (Family Medicine), Faculty of Postgraduate Studies.

4 Sovetskaya ul., Tver, 170100

Russian Federation

K. A. Nikolskaya

Moscow Clinical Scientific Center, Moscow Healthcare Department

Email: fake@neicon.ru

Nikolskaya Karina A. – MD, PhD, Senior Research Fellow, Department of Pancreatic and Biliary Tract Pathology.

86 Shosse Entuziastov, Moscow, 111123

Russian Federation

P. V. Banifatov

Moscow Clinical Scientific Center, Moscow Healthcare Department

Email: fake@neicon.ru

Banifatov Petr V. – MD, PhD, Doctor of Ultrasonic Diagnostics.

86 Shosse Entuziastov, Moscow, 111123

Russian Federation

References

  1. Sabater L, Ausania F, Bakker OJ, Boadas J, Domínguez-Muñoz JE, Falconi M, Fernández-Cruz L, Frulloni L, González-Sánchez V, Lariño-Noia J, Lindkvist B, Lluís F, Morera-Ocón F, Martín-Pérez E, Marra-López C,Moya-Herraiz Á, Neoptolemos JP, PascualI, Pérez-Aisa Á, Pezzilli R, Ramia JM, Sánchez B, Molero X, Ruiz-Montesinos I, Vaquero EC, de-Madaria E. Evidence-based Guidelinesfor the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. Ann Surg. 2016;264(6):949–58. doi: 10.1097/SLA.0000000000001732.
  2. Löhr JM, Dominguez-Munoz E, Rosendahl J,Besselink M, Mayerle J, Lerch MM, Haas S,Akisik F, Kartalis N, Iglesias-Garcia J, Keller J,Boermeester M, Werner J, Dumonceau JM, Fockens P, Drewes A, Ceyhan G, Lindkvist B, Drenth J, Ewald N, Hardt P, de Madaria E, Witt H, Schneider A, Manfredi R, Brøndum FJ, Rudolf S, Bollen T, Bruno M; HaPanEU/UEG WorkingGroup. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153–99. doi: 10.1177/2050640616684695.
  3. Бордин ДС, Кучерявый ЮА. Ключевые позиции панъевропейских клинических рекомендаций по диагностике и лечению хронического панкреатита в фокусе гастроэнтеролога. Русский медицинский журнал. 2017;(10):730–7.
  4. Козлов ИА, Вишневский ВА, Чжао АВ. Хирургическое лечение осложненного хронического панкреатита. Высокотехнологическая медицина. 2017;4(1):43–55.
  5. Коротько ГФ. Постпрандиальная секреция поджелудочной железы. Краснодар; 2017. 132 с.
  6. Губергриц НБ, Беляева НВ. Новости мировой панкреатологии (по материалам совместной встречи Международной ассоциации панкреатологов и Корейской панкреатобилиарной ассоциации, Южная Корея, Сеул, 4–7 сентября 2013 г.). Вестник клуба панкреатологов. 2014;(1):4–10.
  7. Губергриц НБ, Казюлин АН. Метаболическая панкреатология. Донецк: Лебедь; 2011. 460 с.
  8. Tiengo A, Vigili de Kreutzenberg S, Del Prato S. Diabetes in pancreatitis, pancreatectomyand other pancreatic diseases. In: Ghigo E,Porta M, editors. Diabetes secondary to endocrine and pancreatic disorders. Front Diabetes.Vol. 22. Basel: Karger; 2014. p. 119–43. doi: 10.1159/000357252.
  9. Yuasa Y, Murakami Y, Nakamura H, Uemura K,Ohge H, Sudo T, Hashimoto Y, Nakashima A,Hiyama E, Sueda T. Histological loss of pancreatic exocrine cells correlates with pancreatic exocrine function after pancreatic surgery. Pancreas. 2012;41(6):928–33. doi: 10.1097/MPA.0b013e31823d837d.
  10. Sabater L, Pareja E, Aparisi L, Calvete J, Camps B, Sastre J, Artigues E, Oviedo M, Trullenque R, Lledó S. Pancreatic function after severe acutebiliary pancreatitis: the role of necrosectomy. Pancreas. 2004;28(1):65–8.
  11. Reddy MS, Singh S, Singh R, Singh K, Singh G.Morphological and functional outcome after pancreatic necrosectomy and lesser sac lavage for necrotizing pancreatitis. Indian J Gastroenterol. 2007;26(5):217–20.
  12. Hildebrand P, Dudertadt S, Czymek R, Bader FG, Roblick UJ, Bruch HP, Jungbluth T. Different surgical strategies for chronic pancreatitis significantly improve long-term outcome: a comparative single center study. Eur J Med Res. 2010;15(8):351–6. doi: 10.1186/2047-783X-15-8-351.
  13. Bachmann K, Tomkoetter L, Kutup A, Erbes J,Vashist Y, Mann O, Bockhorn M, Izbicki JR. Isthe Whipple procedure harmful for long-termoutcome in treatment of chronic pancreatitis? 15-years follow-up comparing the outcome after pylorus-preserving pancreatoduodenectomy and Frey procedure in chronic pancreatitis. Ann Surg. 2013;258(5):815–20. doi: 10.1097/SLA.0b013e3182a655a8.
  14. Keck T, Adam U, Makowiec F, Riediger H, Wellner U, Tittelbach-Helmrich D, Hopt UT. Shortand long-term results of duodenum preservation versus resection for the management of chronic pancreatitis: a prospective, randomized study. Surgery. 2012;152(3 Suppl 1):S95– S102. doi: 10.1016/j.surg.2012.05.016.
  15. Хатьков ИЕ, Маев ИВ, Абдулхаков СР, Алексеенко СА, Алиева ЭИ, Алиханов РБ, Бакулин ИГ, Барановский АЮ, Белобородова ЕВ, Белоусова ЕА, Буриев ИМ, Быстровская ЕВ, Вертянкин СВ, Винокурова ЛВ, Гальперин ЭИ, Горелов АВ, Гриневич ВБ, Данилов МВ, Дарвин ВВ, Дубцова ЕА, Дюжева ТГ, Егоров ВИ, Ефанов МГ, Захарова НВ, Загайнов ВЕ, Ивашкин ВТ, Израилов РЕ, Корочанская НВ, Корниенко ЕА, Коробка ВЛ, Коханенко НЮ, Кучерявый ЮА, Ливзан МА, Лоранская ИД, Никольская КА, Осипенко МФ, Охлобыстин АВ, Пасечников ВД, Плотникова ЕЮ, Полякова СИ, Саблин ОА, Симаненков ВИ, Урсова НИ, Цвиркун ВВ, Цуканов ВВ, Шабунин АВ, Бордин ДС. Российский консенсус по диагностике и лечению хронического панкреатита. Терапевтический архив. 2017;(2):105–13. doi: 10.17116/ terarkh2017892105-113.
  16. Halloran CM, Cox TF, Chauhan S, Raraty MG, Sutton R, Neoptolemos JP, Ghaneh P. Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study. Pancreatology. 2011;11(6):535–45. doi: 10.1159/000333308.
  17. Bock EA, Hurtuk MG, Shoup M, Aranha GV. Late complications after pancreaticoduodenectomy with pancreaticogastrostomy. J Gastrointest Surg. 2012;16(5):914–9. doi: 10.1007/s11605-011-1805-2.
  18. Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, Falconi M; Exocrine Pancreatic Insufficiency collaborative (EPIc) Group. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol. 2013;19(44):7930–46. doi: 10.3748/wjg.v19.i44.7930.
  19. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973;288(16):813–5. doi: 10.1056/NEJM197304192881603.
  20. Löhr JM, Oliver MR, Frulloni L. Synopsis of recentguidelines on pancreatic exocrine insufficiency. United European Gastroenterol J. 2013;1(2):79–83. doi: 10.1177/2050640613476500.
  21. Benini L, Amodio A, Campagnola P, Agugiaro F, Cristofori C, Micciolo R, Magro A, Gabbrielli A, Cabrini G, Moser L, Massella A, Vantini I, Frulloni L. Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection. Pancreatology. 2013;13(1):38–42. doi: 10.1016/j.pan.2012.11.307.
  22. Fischer B, Hoh S, Wehler M, Hahn EG, Schneider HT. Faecal elastase-1: lyophilization of stool samples prevents false low results in diarrhoea. Scand J Gastroenterol. 2001;36(7):771–4. doi: http://dx.doi.org/10.1080/00365520119999.
  23. Hardt PD, Hauenschild A, Nalop J, Marzeion AM, Porsch-Ozcürümez M, Luley C, Sziegoleit A, Kloer HU. The commercially available ELISA for pancreatic elastase 1 based on polyclonal antibodies does measure an as yet unknown antigen different from purified elastase 1. Binding studies and clinical use in patients with exocrine pancreatic insufficiency. Z Gastroenterol. 2003;41(9):903–6. doi: 10.1055/s-2003-41832.
  24. Domínguez-Muñoz JE, Nieto L, Vilariño M, Lourido MV, Iglesias-García J. Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis. Pancreas. 2016;45(2):241–7. doi: 10.1097/MPA.0000000000000434.
  25. Keller J, Meier V, Wolfram KU, Rosien U, Layer P. Sensitivity and specificity of an abbreviated (13)C-mixed triglyceride breath test for measurement of pancreatic exocrine function. United European Gastroenterol J. 2014;2(4):288–94. doi: 10.1177/2050640614542496.
  26. Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther. 2013;37(7):691–702. doi: 10.1111/apt.12236.
  27. Хатьков ИЕ, Маев ИВ, Бордин ДС, Кучерявый ЮА, Абдулхаков СР, Алексеенко СА, Алиева ЭИ, Алиханов РБ, Бакулин ИГ, Барановский АЮ, Белобородова ЕВ, Белоусова ЕА, Буриев ИМ, Быстровская ЕВ, Вертянкин СВ,Винокурова ЛВ, Гальперин ЭИ, Горелов АВ,Гриневич ВБ, Данилов МВ, Дарвин ВВ, Дубцова ЕА, Дюжева ТГ, Егоров ВИ, Ефанов МГ, Захарова НВ, Загайнов ВЕ, Ивашкин ВТ, Израилов РЕ, Корочанская НВ, Корниенко ЕА, Коробка ВЛ, Коханенко НЮ, Ливзан МА, Лоранская ИД, Никольская КА, Осипенко МФ, Охлобыстин АВ, Пасечников ВД, Плотникова ЕЮ, Полякова СИ, Саблин ОА, Симаненков ВИ, Урсова НИ, Цвиркун ВВ, Цуканов ВВ,Шабунин АВ. Российский консенсус по диагностике и лечению хронического панкреатита: акцент на нутритивный статус и вопросыпитания. Фарматека. 2016;(S5-16):27–32.
  28. American Diabetes Association. Diagnosis andclassification of diabetes mellitus. DiabetesCare. 2014;37 Suppl 1:S81–90. doi: 10.2337/dc14-S081.
  29. Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28(4):338–42. doi: 10.1002/dmrr.2260.
  30. Rickels MR, Bellin M, Toledo FG, Robertson RP, Andersen DK, Chari ST, Brand R, Frulloni L, Anderson MA, Whitcomb DC; PancreasFest Recommendation Conference Participants. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest2012. Pancreatology. 2013;13(4):336–42. doi: 10.1016/j.pan.2013.05.002.
  31. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011;34 Suppl 2:S184–90. doi: 10.2337/dc11-s216.
  32. Cavallini G, Vaona B, Bovo P, Cigolini M, Rigo L, Rossi F, Tasini E, Brunori MP, Di Francesco V, Frulloni L. Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance. Dig Dis Sci. 1993;38(3):497–501. doi: https://doi.org/10.1007/BF01316505.
  33. Raz I, Bhatt DL, Hirshberg B, Mosenzon O, Scirica BM, Umez-Eronini A, Im K, Stahre C, Buskila A, Iqbal N, Greenberger N, Lerch MM. Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the dipeptidyl peptidase-4 inhibitor saxagliptin. Diabetes Care.2014;37(9):2435–41. doi: 10.2337/dc13-2546.
  34. Lamont BJ, Andrikopoulos S. Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology? J Endocrinol. 2014;221(1):T43–61. doi: 10.1530/JOE-13-0577.
  35. Kuo P, Stevens JE, Russo A, Maddox A, Wishart JM, Jones KL, Greville H, Hetzel D, Chapman I, Horowitz M, Rayner CK. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis – effects of pancreatic enzyme supplementation. J Clin Endocrinol Metab. 2011;96(5):E851–5. doi: 10.1210/jc.2010-2460.
  36. Makuc J. Management of pancreatogenic diabetes: challenges and solutions. Diabetes Metab Syndr Obes. 2016;9:311–5. doi: 10.2147/DMSO.S99701.
  37. de-Madaria E, Abad-González A, Aparicio JR, Aparisi L, Boadas J, Boix E, de-LasHeras G, Domínguez-Muñoz E, Farré A, Fernández-Cruz L, Gómez L, Iglesias-García J, García-Malpartida K, Guarner L, Lariño-Noia J, Lluís F, López A, Molero X, Moreno-Pérez O, Navarro S, Palazón JM, Pérez-Mateo M, Sabater L,Sastre Y, Vaquero EC, Martínez J. The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). Pancreatology. 2013;13(1):18–28. doi: 10.1016/j.pan.2012.11.310.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bordin D.S., Dubtsova E.A., Vinokurova L.V., Kolbasnikov S.V., Nikolskaya K.A., Banifatov P.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies